• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Alzheimer's Disease

    Recent news which mentions Alzheimer's Disease

    < Previous 1 2 3 Next >
    FDA commissioner praises Eli Lilly Alzheimer's treatment results
    Tags Alzheimer's disease Business World News
    From CNBC.com News
    Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
    Tags Eli Lilly and Co Health care industry Politics
    From CNBC.com News
    Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
    Tags Health care industry Eisai Co Ltd Eli Lilly and Co
    From CNBC.com News
    March 2023 Miscellany
    Tags AC Immune (ACIU) Alzheimer's Disease Breast Cancer
    From Stock Gumshoe
    Getting Back to You on Anavex, Cassava, metformin and more
    Tags metformin Parkinson's Disease Biogen Idec (BIIB)
    From Stock Gumshoe
    Relevant Updates – December 2022
    Tags Eisai (ESALY) Moderna Therapeutics (MRNA) Lexeo Therapeutics
    From Stock Gumshoe
    Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
    Tickers MOR RHHBF RHHBY RHHVF
    Tags Alzheimer’s Large Cap News
    From Benzinga
    A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
    Tags Local food Health Alzheimer's disease
    From CNBC.com News
    Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
    Tickers SPRC
    Tags Benzinga Alzheimer's disease SPRC
    From Benzinga
    Odd & Ends – October 2022
    Tags Doc Gumshoe Eisai (ESALY) Alzheimer's Disease
    From Stock Gumshoe
    These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
    Tickers ABOS ACIU ALZN ANVS
    Tags Small Cap General ABOS
    From Benzinga
    Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
    Tickers BIIB ESALY
    Tags Market News Analyst Color Marc Goodman
    From Benzinga
    Following Up on Your Suggestions – September 2022
    Tickers DIET
    Tags Pfizer (PFE) GlaxoSmithKline (GSK) NervGen Pharma (NGEN/V NGENF)
    From Stock Gumshoe
    Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
    Tickers DGX
    Tags NYSE:DGX Quest Diagnostics Events, Media & Communications
    From 3BL Media: Corporate Social Responsibility, Energy and Health News
    EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
    Tickers CGTX
    Tags Biotech Health Care Alzheimer's disease
    From Benzinga
    Alzheimer’s Drug Development — July Responses to Questions & Requests
    Tags TauRX Pharmaceuticals Genting Berhad (GEBHY) Alzheimer's Disease
    From Stock Gumshoe
    AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
    Tickers ABBV ALEC
    Tags Small Cap General Briefs
    From Benzinga
    Alzheimer’s Disease June 2022 – Possible Signs of Progress
    Tags Cassava Sciences (SAVA) Alzheimer's Disease TauRX Pharmaceuticals
    From Stock Gumshoe
    Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
    Tickers BIIB
    Tags News Alzheimer's disease Benzinga
    From Benzinga
    Alzheimer’s Disease May 2022 – Is There Anything New?
    Tags Eisai (ESALY) Alzheimer's Disease inflammation
    From Stock Gumshoe
    Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
    Tickers BIIB ESALF ESALY
    Tags Health Care ESALY Benzinga
    From Benzinga
    New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
    Tickers SAVA
    Tags General Small Cap Alzheimer's disease
    From Benzinga
    EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
    Tickers LGVN
    Tags General Phase 2 Trial Market News
    From Benzinga
    Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
    Tickers BIIB
    Tags Government Aduhelm Alzheimer's disease
    From Benzinga
    EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
    Tickers LGVN
    Tags General Biotech Benzinga
    From Benzinga
    Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
    Tickers BIIB ESALF ESALY
    Tags ESALY Alzheimer's disease Benzinga
    From Benzinga
    Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
    Tickers BIIB
    Tags BIIB General Market News
    From Benzinga
    Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
    Tickers PRTA
    Tags News Health Care PRTA
    From Benzinga
    Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
    Tickers GANX
    Tags Parkinson’s Disease Preclinical Phase Market News
    From Benzinga
    Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
    Tickers BIIB ESALF ESALY
    Tags General Contracts BIIB
    From Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.